Black Diamond Therapeutic Q3 EPS $(0.45) Beats $(0.46) Estimate; Cash, Cash Equivalents, And Investments Of $144.3M, Expected To Be Sufficient To Fund Operations Into 1H Of 2025
Black Diamond Therapeutic Q3 EPS $(0.45) Beats $(0.46) Estimate; Cash, Cash Equivalents, And Investments Of $144.3M, Expected To Be Sufficient To Fund Operations Into 1H Of 2025
黑鑽治療第三季度每股收益爲0.45美元，超過了美元（0.46）的預期；現金、現金等價物和投資爲1.443億美元，預計足以爲2025年上半年的運營提供資金
Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.46) by 2.17 percent. This is a 25 percent increase over losses of $(0.60) per share from the same period last year.
黑鑽療法（納斯達克股票代碼：BDTX）公佈季度每股虧損0.45美元，比分析師普遍估計的0.46美元（0.46美元）高出2.17％。這比去年同期每股虧損美元（0.60美元）增加了25％。